Alibaba to Pay $600M Over Allegations of Illegal Pharmaceutical Sales in the U.S.

(MedPage Today) — The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals…